Abstract:Cortex Lycii, as a kind of traditional Chinese medicines, have shown prospects in the prevention of diabetes and its complications. However, there is comparatively little information regarding the characterization of potentially hypoglycemic compounds derived from Cortex Lycii. In this study, we performed a global non-selective investigation of α-glucosidase inhibitors in Cortex Lycii based on a bioactivity-labeling high-resolution mass spectrometry–metabolomics method. Samples of Cortex Lycii were collected from different Chinese provinces and their ethyl acetate extracts were analyzed using an in vitro α-glucosidase inhibition assay for bioactivity-labeling. The ethyl acetate extracts were also subjected to liquid chromatography-mass spectrometry analysis and multivariate data analysis was subsequently conducted to identify correlations between the bioactivity measured from the enzyme-involved test and the profiles obtained based on high-resolution mass spectrometry. The variables contributing significantly to the separation of the more-active from the less-active samples were considered to indicate the potential target ions of active compounds. MS/MS fragment patterns and nuclear magnetic resonance analyses were used to identify the potential target ions. The developed platform mentioned above facilitated rapid identification of four α-glucosidase inhibitors, namely, N-p-trans-coumaroyltyramine (1), N-trans-caffeoyl-tyramine (2), (9R,10E,12Z)-9-hydroxy-10,12-octadecadienoic acid (3a), and (9S,10E,12Z)-9-hydroxy-10,12-octadecadienoic acid (3b) from Cortex Lycii. The α-glucosidase inhibitory activities of compounds 3a and 3b with IC50 values of 1.0413±0.0551 and 1.0423±0.0049 mM, respectively, are reported here for the first time. Enzyme kinetics revealed that both 3a and 3b were non-competitive inhibitors of α-glucosidase, with Ki values of 2.20 and 2.24 mM, respectively. In short, the presented work identified compounds 3a and 3b as potential α-glucosidase inhibitors with higher inhibitory activity and a different mode of inhibition compared to the standard α-glucosidase inhibitor, acarbose. The integrated approach adopted in this study can be extended as a normalized procedure to rapidly identify active compounds, even from complex extracts, and can readily be adapted for the study of other natural products.

α-Glucosidase inhibitory triterpenoids from Euonymus fortunei

A New Flavan-3-ol Lactone and Other Constituents from Euonymus Alatus with Inhibitory Activities on Α-Glucosidase and Differentiation of 3T3-L1 Cells.

Bioassay-guided screening and isolation of α-glucosidase and tyrosinase inhibitors from leaves of Morus alba

Two New Triterpenoid Saponins from the Roots Ofgypsophila Paniculata with Potent Α-Glucosidase Inhibition Activity

Screening, Characterization of Trace Α-Glucosidase Inhibitors from the Root of Pueraria Lobata and Evaluation of Their Hypoglycemic Activity

Identification and Isolation of α-Glucosidase Inhibitors from Siraitia grosvenorii Roots Using Bio-Affinity Ultrafiltration and Comprehensive Chromatography

Three New Sesquiterpene Pyridine Alkaloids from Euonymus Fortunei

Triterpenoids and meroterpenoids with α-glucosidase inhibitory activities from the fruiting bodies of Ganoderma australe

Terpenoids with α-glucosidase inhibitory activity from Rhododendron minutiflorum Hu

Bio-assay guided isolation and identification of α-glucosidase inhibitors from the leaves of Aquilaria sinensis

Structurally Diverse Triterpene-26-oic Acids as Potential Dual ACL and ACC1 Inhibitors from the Vulnerable Conifer Keteleeria fortunei

Pentacyclic triterpenes as α-glucosidase and α-amylase inhibitors: Structure-activity relationships and the synergism with acarbose.

Bioactive ellagitannins and phenylpropanoid glycosides from the seed of Torreya grandis

Diterpenoids with Α-Glucosidase Inhibitory Activities from the Fruits of Vitex Trifolia Linn.

[Bioactivity Guided Isolation of Alpha-Glucosidase Inhibitor from Whole Herbs of Crossostephium Chinense].

Identification of Α-Glucosidase Inhibitors from Cortex Lycii Based on a Bioactivity-Labeling High-Resolution Mass Spectrometry–metabolomics Investigation

Acylated sucroses and butenolide analog from the leaves of Tripterygium wilfordii Hook. f. and their potential anti-tyrosinase effects

A new hemiacetal chromone racemate and α-glucosidase inhibitors from Ficus tikoua Bur

Aromatic Constituents of Euonymus fortunei

Structure Elucidation of a Novel Polysaccharide Isolated from Euonymus fortunei and Establishing Its Antioxidant and Anticancer Properties

Triterpenoids from the fruits of Melia toosendan Sieb. et Zucc. with α -glucosidase inhibitory activities